Φορτώνει......
Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide
CONTEXT: Diazoxide, the only U.S. Food and Drug Administration–approved drug to treat hyperinsulinemic hypoglycemia, has been associated with several adverse events, which has raised concerns about the safety of this drug. Existing reports are limited to small studies and case reports. OBJECTIVE: To...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Clin Endocrinol Metab |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Endocrine Society
2018
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6207144/ https://ncbi.nlm.nih.gov/pubmed/30247666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2018-01613 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|